   DEPARTMENT OF HEALTH & HUMAN SERVICES default		         		Public
Health Service

 ADVANCE \r360  ADVANCE \d3 	Food and Drug Administration

 ADVANCE \r360 	Rockville, MD  20857

February 22, 2005

Deborah A. Jaskot

Vice President, Regulatory Affairs

Teva Pharmaceuticals USA

1090 Horsham Road

North Wales, PA  19454

Dear Ms. Jaskot:

Your petition requesting the Food and Drug Administration to determine
whether Vioxx Tablets, manufactured by Merck has been voluntarily
withdrawn or withheld from sale for safety or efficacy reasons, was
received by this office on 02/22/2005.  It was assigned docket number
2005P-0079/CP 1 and it was filed on 02/22/2005. Please refer to this
docket number in future correspondence on this subject with the Agency.

Please note that the acceptance of the petition for filing is a
procedural matter in that it in no way reflects an agency decision on
the substantive merits of the petition.

Sincerely,

Lyle D. Jaffe

Division of Dockets Management

Office of Management Programs

Office of Management

                  

